DSG2 and esophageal squamous cell carcinoma: In the present study, although we demonstrated that DSG2 is a useful biomarker for the diagnosis of ESCC and EJA, its sensitivity requires improvement; however, to our knowledge, this is the first report on the diagnostic value of serum DSG2 for early-stage cancer.